Cargando…

Genetic alterations detected by comparative genomic hybridization in BRCAX breast and ovarian cancers of Brazilian population

BACKGROUND: About 5–10% of breast/ovarian cancers are hereditary. However, for a large proportion of cases (around 50%), the genetic cause remains unknown. These cases are grouped in a separated BRCAX category. The aim of this study was to identify genomic alterations in BRCA1/BRCA2 wild-type tumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Felicio, Paula Silva, Bidinotto, Lucas Tadeu, Melendez, Matias Eliseo, Grasel, Rebeca Silveira, Campacci, Natalia, Galvão, Henrique C.R., Scapulatempo-Neto, Cristovam, Dufloth, Rozany Mucha, Evangelista, Adriane Feijó, Palmero, Edenir Inêz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007956/ https://www.ncbi.nlm.nih.gov/pubmed/29938003 http://dx.doi.org/10.18632/oncotarget.25537

Ejemplares similares

Genetic and epigenetic characterization of the BRCA1 gene in Brazilian women at-risk for hereditary breast cancer
por: Felicio, Paula Silva, et al.
Publicado: (2016)

New insights on familial colorectal cancer type X syndrome
por: Garcia, Felipe Antonio de Oliveira, et al.
Publicado: (2022)

Differential Profile of BRCA1 vs. BRCA2 Mutated Families: A Characterization of the Main Differences and Similarities in Patients
por: Fernandes, Gabriela Carvalho, et al.
Publicado: (2019)

Using Co-segregation and Loss of Heterozygosity Analysis to Define the Pathogenicity of Unclassified Variants in Hereditary Breast Cancer Patients
por: Grasel, Rebeca Silveira, et al.
Publicado: (2020)

Whole-Exome Sequencing Identifies Pathogenic Germline Variants in Patients with Lynch-Like Syndrome
por: dos Santos, Wellington, et al.
Publicado: (2022)

Association of polymorphisms with a family history of cancer and the presence of germline mutations in the BRCA1/BRCA2 genes
por: Fernandes, Gabriela C., et al.
Publicado: (2016)

Clinical management of women in BRCAX families: issues and controversies
por: Mitchell, G
Publicado: (2012)

MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol
por: Arantes, Lidia Maria Rebolho Batista, et al.
Publicado: (2016)

Identification of MicroRNA Expression Profiles Related to the Aggressiveness of Salivary Gland Adenoid Cystic Carcinomas
por: Zanon, Maicon Fernando, et al.
Publicado: (2023)

Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry
por: Fernandes, Gabriela C., et al.
Publicado: (2016)

Molecular characterization of breast cancer cell lines by clinical immunohistochemical markers
por: Mota, André de Lima, et al.
Publicado: (2017)

Cost-Effectiveness of BRCA 1/2 Genetic Test and Preventive Strategies: Using Real-World Data From an Upper-Middle Income Country
por: Lourenção, Marina, et al.
Publicado: (2022)

Whole‐exome sequencing of non‐BRCA1/BRCA2 mutation carrier cases at high‐risk for hereditary breast/ovarian cancer
por: Felicio, Paula S., et al.
Publicado: (2020)

Cancer-related worry and risk perception in Brazilian individuals seeking genetic counseling for hereditary breast cancer
por: Palmero, Edenir Inêz, et al.
Publicado: (2020)

Accuracy of microRNAs as markers for the detection of neck lymph node metastases in patients with head and neck squamous cell carcinoma
por: de Carvalho, Ana Carolina, et al.
Publicado: (2015)

Erratum: Accuracy of microRNAs as markers for the detection of neck lymph node metastases in patients with head and neck squamous cell carcinoma
por: de Carvalho, Ana Carolina, et al.
Publicado: (2015)

CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy
por: Alves, Wilson Eduardo Furlan Matos, et al.
Publicado: (2019)

Molecular Classification of Thyroid Nodules with Indeterminate Cytology: Development and Validation of a Highly Sensitive and Specific New miRNA-Based Classifier Test Using Fine-Needle Aspiration Smear Slides
por: dos Santos, Marcos Tadeu, et al.
Publicado: (2018)

Pyknon-Containing Transcripts Are Downregulated in Colorectal Cancer Tumors, and Loss of PYK44 Is Associated With Worse Patient Outcome
por: Evangelista, Adriane Feijó, et al.
Publicado: (2020)

Early Age at First Sexual Intercourse is Associated with Higher Prevalence of High-grade Squamous Intraepithelial Lesions (HSIL)
por: Xavier-Júnior, José Cândido Caldeira, et al.
Publicado: (2017)

Genome-Wide Identification of BrCAX Genes and Functional Analysis of BrCAX1 Involved in Ca(2+) Transport and Ca(2+) Deficiency-Induced Tip-Burn in Chinese Cabbage (Brassica rapa L. ssp. pekinensis)
por: Cui, Shuning, et al.
Publicado: (2023)

PIK3CA mutations are frequently observed in BRCAX but not BRCA2 -associated male breast cancer
por: Deb, Siddhartha, et al.
Publicado: (2013)

Somatic Copy Number Alterations and Associated Genes in Clear-Cell Renal-Cell Carcinoma in Brazilian Patients
por: Fernandes, Flávia Gonçalves, et al.
Publicado: (2021)

Profile of esophageal squamous cell carcinoma mutations in Brazilian patients
por: Munari, Fernanda Franco, et al.
Publicado: (2021)

Insights on variant analysis in silico tools for pathogenicity prediction
por: Garcia, Felipe Antonio de Oliveira, et al.
Publicado: (2022)

Oncogenetics service and the Brazilian public health system: the experience of a reference Cancer Hospital
por: Palmero, Edenir I., et al.
Publicado: (2016)

Identification of hereditary cancer in the general population: development and validation of a screening questionnaire for obtaining the family history of cancer
por: Campacci, Natalia, et al.
Publicado: (2017)

Enhanced RAD21 cohesin expression confers poor prognosis in BRCA2 and BRCAX, but not BRCA1 familial breast cancers
por: Yan, Max, et al.
Publicado: (2012)

BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts
por: Lee, Joo-Yeon, et al.
Publicado: (2018)

Haplotypic characterization of BRCA1 c.5266dupC, the prevailing mutation in Brazilian hereditary breast/ovarian cancer
por: Gomes, Renan, et al.
Publicado: (2020)

Family-specific, novel, deleterious germline variants provide a rich resource to identify genetic predispositions for BRCAx familial breast cancer
por: Wen, Hongxiu, et al.
Publicado: (2014)

miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil
por: Pessôa-Pereira, Danielle, et al.
Publicado: (2020)

Correlation of p16 immunohistochemistry with clinical and epidemiological features in oropharyngeal squamous-cell carcinoma
por: de C. Ferreira, Chrystiano, et al.
Publicado: (2021)

The Brazilian TP53 mutation (R337H) and sarcomas
por: Volc, Sahlua Miguel, et al.
Publicado: (2020)

Molecular Profiling of a Rare Rosette-Forming Glioneuronal Tumor Arising in the Spinal Cord
por: Bidinotto, Lucas Tadeu, et al.
Publicado: (2015)

Genomic rearrangements in BRCA1 and BRCA2: A literature review
por: Ewald, Ingrid Petroni, et al.
Publicado: (2009)

Expression of tumor suppressors miR-195 and let-7a as potential biomarkers of invasive breast cancer
por: Marques, Marcia M., et al.
Publicado: (2018)

A microRNA signature profile in EBV(+) diffuse large B-cell lymphoma of the elderly
por: de Andrade, Tathiana Azevedo, et al.
Publicado: (2014)

HER Family Receptors are Important Theranostic Biomarkers for Cervical Cancer: Blocking Glucose Metabolism Enhances the Therapeutic Effect of HER Inhibitors
por: Martinho, Olga, et al.
Publicado: (2017)

A computational approach for the discovery of significant cancer genes by weighted mutation and asymmetric spreading strength in networks
por: Cutigi, Jorge Francisco, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aj1s9g85mpt1si8p8gdnqq9ifk